Imatinib Mesylate for Patients with Recurrent or Metastatic Gastrointestinal Stromal Tumors Expressing KIT: A Decade Experience from Taiwan
Chun‐Nan Yeh(Chang Gung University), Miin‐Fu Chen(Chang Gung Memorial Hospital), Tsung-Wen Chen(Chang Gung University), Jen‐Shi Chen(Linkou Chang Gung Memorial Hospital), Chun‐Yi Tsai(Chang Gung University), Yi-Yin Jan(Chang Gung Memorial Hospital), Chi‐Tung Cheng(Chang Gung Memorial Hospital), Yen‐Yang Chen(Chang Gung University), Jeng‐Hwei Tseng(Chang Gung University)
Cited by 47
Related Papers
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
|NEJM Evidence|2022|1.1k
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
|Hepatology|2001|282